These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25130828)

  • 41. Prototypical innate immune mechanism hijacked by leukemia-initiating mutant stem cells for selective advantage and immune evasion in Ptpn11-associated juvenile myelomonocytic leukemia.
    Zheng H; Zhao P; Tan Z; Yu WM; Werner J; Stieglitz E; Porter C; Chandrakasan S; Wechsler D; Mendez-Ferrer S; Qu CK
    Res Sq; 2024 Aug; ():. PubMed ID: 39149498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful management of therapy-related chronic myelomonocytic leukemia with cytarabine, aclarubicin, and azacitidine following tegafur/gimeracil/oteracil.
    Nakako S; Takakuwa T; Ichimura H; Okamura H; Nanno S; Nishimoto M; Nakashima Y; Koh H; Hino M; Nakamae H
    Clin Case Rep; 2021 Jun; 9(6):e04298. PubMed ID: 34194799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of Facility Type on Survival in Chronic Myelomonocytic Leukemia: A Propensity Score Matched, National Cancer Database Analysis.
    Tharakan S; Feld J; Van Hyfte G; Mascarenhas J; Tremblay D
    Clin Lymphoma Myeloma Leuk; 2024 Oct; 24(10):e385-e391.e1. PubMed ID: 39003100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Temporal trend in survival for chronic myelomonocytic leukemia in the US: a population-based study.
    Lesegretain A; Brunner A; Benzohra A; Fathi AT
    Leuk Lymphoma; 2023 Dec; 64(13):2156-2164. PubMed ID: 37715313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebral localization of chronic myelomonocytic leukemia and improvement with high-dose cytarabine: A case report.
    Haméon C; Machet A; Drieu La Rochelle L; Vallet N; Lejeune J; Ravalet N; Cottier JP; Hérault O; Gyan E
    EJHaem; 2023 Aug; 4(3):844-847. PubMed ID: 37601847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kidney and Urinary Tract Involvement in Chronic Myelomonocytic Leukemia.
    Attieh RM; Begum F; Chitty D; Izzedine H; Jhaveri KD
    Kidney Med; 2024 Feb; 6(2):100769. PubMed ID: 38313809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cabot rings in chronic myelomonocytic leukemia.
    Strasser B; Haushofer A
    Blood; 2023 Nov; 142(20):1757. PubMed ID: 37971756
    [No Abstract]   [Full Text] [Related]  

  • 48. Periungual pyogenic granulomas after ravulizumab therapy in a child with acute myelomonocytic leukemia treated with hematopoietic stem cell transplant.
    Iznardo H; López-Torija I; Mateu-Arrom L; Escribano-Sanz P; Puig L; Roé E
    Pediatr Dermatol; 2024 Jun; ():. PubMed ID: 38858093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resolution of an unexpected ABO typing discrepancy in a 9-month-old patient with juvenile myelomonocytic leukemia.
    Hermelin D; Zhang D; Blackall D
    Clin Case Rep; 2020 Dec; 8(12):2358-2360. PubMed ID: 33363740
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lysozyme nephropathy in chronic myelomonocytic leukemia.
    Patel AB; Miles RR; Deininger MW
    Clin Case Rep; 2019 Jun; 7(6):1263-1264. PubMed ID: 31183108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Robin M, de Wreede LC, Padron E, et al. Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis. Blood. 2022;140(12):1408-1418.
    Blood; 2023 Jun; 141(26):3232-3233. PubMed ID: 37383000
    [No Abstract]   [Full Text] [Related]  

  • 52. Refining risk stratification to improve prognosis in juvenile myelomonocytic leukemia.
    Nunn JL; Fraser CJ
    Haematologica; 2024 Sep; 109(9):2758-2760. PubMed ID: 38813703
    [No Abstract]   [Full Text] [Related]  

  • 53. Erratum: Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay.
    JCO Precis Oncol; 2024 Jan; 8():e2300667. PubMed ID: 38215356
    [No Abstract]   [Full Text] [Related]  

  • 54. Correction to: A case of sudden hearing loss in a patient with chronic myelomonocytic leukemia.
    Babakhanlou R; Nader ME; Alvarado Y
    Ann Hematol; 2024 Jan; 103(1):371. PubMed ID: 37919482
    [No Abstract]   [Full Text] [Related]  

  • 55. Spontaneous remission without treatment of acute myelomonocytic leukemia associated with COVID-19 infection.
    Peñuela R; Hernandez I; Fernandes-Pineda M; Cortina L; Zapata D; Urrego O; Herrera J; Saenz I; Orduz R; Mejia F; Moreno L; Velazco M
    Hematol Transfus Cell Ther; 2024; 46(4):506-510. PubMed ID: 38199950
    [No Abstract]   [Full Text] [Related]  

  • 56. Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review.
    Patnaik MM; Lasho T
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):460-464. PubMed ID: 33275673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia].
    Shao Q; Wang ZD; Zheng XL; Dong L; Han DM; Yan HM; Wang HX; Duan LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1058-62. PubMed ID: 25130828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical Study on Treatment of Juvenile Myelomonocytic Leukemia with Haploidentical-Hematopoietic Stem Cell Transplantation].
    Ding L; Zhu H; Han DM; Wang ZD; Zheng XL; Dong L; Yan HM; Liu J; Zhu L; Xue M; Guo ZK; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1524-1527. PubMed ID: 29070137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the International JMML Working Group.
    Manabe A; Okamura J; Yumura-Yagi K; Akiyama Y; Sako M; Uchiyama H; Kojima S; Koike K; Saito T; Nakahata T;
    Leukemia; 2002 Apr; 16(4):645-9. PubMed ID: 11960345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia.
    Motohashi K; Fujisawa S; Doki N; Kobayashi T; Mori T; Usuki K; Tanaka M; Fujiwara S; Kako S; Aoyama Y; Onoda M; Yano S; Gotoh M; Kanamori H; Takahashi S; Okamoto S;
    Leuk Lymphoma; 2018 Jun; 59(6):1332-1337. PubMed ID: 29032731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.